Probiotic supplementation to mitigate berotralstat gastrointestinal side effects: a multicenter case series from the ITACA network

IntroductionBerotralstat, the first oral plasma kallikrein inhibitor approved for hereditary angioedema (HAE) prophylaxis, may be associated with gastrointestinal (GI) side effects, particularly during the first three months of therapy. Probiotics have been shown to reduce GI disturbances in several...

Description complète

Détails bibliographiques

Auteurs principaux:	Antonio Gidaro, Maria Domenica Guarino, Francesco Arcoleo, Donatella Bignardi, Cristian D’Antonio, Luisa Brussino, Pietro Accardo, Stefania Nicola, Stefano Pucci, Miriam Cognigni, Valentina Popescu Janu, Chiara Cogliati, Emanuele Bizzi, Mauro Cancian
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2026-04-01
Collection:	Frontiers in Immunology
Sujets:	berotralstat gastrointestinal side effects hereditary angioedema ITACA long term prophylaxis microbiome
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1790199/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!